17 April 2012
The U.S. Supreme Court unanimously ruled in favor of generic drug company Caraco Pharmaceutical Laboratories, finding that generic drug companies can file legal counterclaims against brand name drug companies to get generic drugs on the market faster. Caraco Pharm. Labs., Ltd. v. Novo Nordisk A/S, No. 10-844 (Apr. 17, 2012).